Helius Medical Technologies is trading at $2.19 (+5.53%), primarily supported by healthcare-sector gains.
- No credible September 3, 2026 company-specific announcement or filing was identified.
- Healthcare sector is up 1.37% as medical-device peers reported strong results; the Nasdaq Composite is also up 0.70%, supporting risk appetite.
- Recent company news includes older developments, but none clearly explains this session’s move.